United States · 
Who invested in Personal Genome Diagnostics?
Personal Genome Diagnostics's investors include Innovatus Capital Partners.
201920202021
$42MRound$103MSeries C
United States · Series C startup
Who invested in Personal Genome Diagnostics
Funding summaryUpdated 26 Oct 2026
$145Mraised across 2 rounds since 2018, from 2 sources
$42MRound$103MSeries C
- Latest round
- Series C, $103MFeb 2021
- Step-upi
- 2.5×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round, $42M Oct 2018
- Biggest round
- $103M Series C · Feb 2021
- Between rounds
- 2.4 years from the last two
The rounds
- Feb 2021Series C$103M
No investor was named in the report.
Reported by Vensana CapitalSEC filing: $98M sold, first sale Feb 2021
- Oct 2018
Founders and team
From the SEC filings it signed: 4 on the team.
- Jack A. CrowleyExecutive Officeri
- Megan A. BaileyExecutive Officer, Directori
- Samuel A. AnguioliExecutive Officeri
- Scott A. GotshallExecutive Officeri
On the board, as filediJames A. LaFranceJustin A. KleinKavita A. PatelKevin A. ReidyLily A. LiLuis A. DiazVictor A. Velculescu
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Personal Genome Diagnostics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Personal Genome Diagnostics
How much has Personal Genome Diagnostics raised?
Personal Genome Diagnostics has raised $145M across 2 rounds since 2018.
When did Personal Genome Diagnostics last raise?
Personal Genome Diagnostics's most recent round was a Series C of $103M in Feb 2021.
What was Personal Genome Diagnostics's biggest round?
Its most recent round, $103M in Feb 2021, is also its largest on record.
Who backed Personal Genome Diagnostics first?
Personal Genome Diagnostics's first round on record, in Oct 2018, was backed by Innovatus Capital Partners.
What stage is Personal Genome Diagnostics at?
Personal Genome Diagnostics's latest named round is a Series C, in Feb 2021.
Where is Personal Genome Diagnostics based?
Personal Genome Diagnostics is based in the United States.
Companies like Personal Genome Diagnostics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.